Synthekine Inc., an engineered cytokine therapeutics company, today announced that data from a Phase 1a/1b clinical trial of its ?/? biased IL-2 partial agonist, STK-012, will be presented in a ...
The abstracts will be available online at annualmeeting.acaai.org, as well as on the Company’s website on the Scientific Events page of the of the Investor section beginning on November 6, 2025.
3d
This new Gemini trick takes your presentation ideas and instantly brings them to life - here's how
To check this out, sign in to the Gemini website with your Google account. If you have a Pro personal or Workspace account, you should be able to try this new skill right away. If you have a free ...
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Updated data from RUBY-3 ...
CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical-stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) to revolutionize the treatment of ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PowerCell Sweden AB ( (SE:PCELL)) has ...
Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Ares Management ( (ARES)) has shared an ...
WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative ...
WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative ...
Here’s when you tune in. Nintendo fans are waiting eagerly for that next big Nintendo Direct. We haven’t had one dedicated to just the first-party games coming out in a good while. In the more recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback